These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25920446)

  • 1. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
    Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R
    Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-gamma agonist protects podocytes from injury.
    Kanjanabuch T; Ma LJ; Chen J; Pozzi A; Guan Y; Mundel P; Fogo AB
    Kidney Int; 2007 Jun; 71(12):1232-9. PubMed ID: 17457378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of rosiglitazone on SMAD2 and SMAD3 signaling in white adipose tissue of diabetic rats.
    Beaudoin MS; Snook LA; Arkell AM; Stefanson A; Wan Z; Simpson JA; Holloway GP; Wright DC
    Obesity (Silver Spring); 2014 Jul; 22(7):1632-42. PubMed ID: 24500776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.
    Ghosh AK; Wei J; Wu M; Varga J
    Biochem Biophys Res Commun; 2008 Sep; 374(2):231-6. PubMed ID: 18627765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.
    Hatanaka H; Koizumi N; Okumura N; Kay EP; Mizuhara E; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6955-63. PubMed ID: 22956604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
    Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
    Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.
    Zhu HY; Li C; Zheng Z; Zhou Q; Guan H; Su LL; Han JT; Zhu XX; Wang SY; Li J; Hu DH
    Biochem Biophys Res Commun; 2015 Mar; 459(1):49-53. PubMed ID: 25704091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.
    Guo N; Woeller CF; Feldon SE; Phipps RP
    J Biol Chem; 2011 May; 286(21):18856-67. PubMed ID: 21454487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
    Nicola T; Ambalavanan N; Zhang W; James ML; Rehan V; Halloran B; Olave N; Bulger A; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L125-34. PubMed ID: 21531777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis.
    Zhang Y; Li X; Fang S; Zhu Z; Yao M; Ying L; Zhu L; Ma Z; Wang W
    Mol Med Rep; 2017 Aug; 16(2):1793-1800. PubMed ID: 28656266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
    Poleni PE; Bianchi A; Etienne S; Koufany M; Sebillaud S; Netter P; Terlain B; Jouzeau JY
    Osteoarthritis Cartilage; 2007 May; 15(5):493-505. PubMed ID: 17140817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.
    Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T
    J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
    Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
    PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
    Yang HC; Ma LJ; Ma J; Fogo AB
    Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
    Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
    EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.